Peter Altman - Aug 17, 2023 Form 4/A - Amendment Insider Report for BioCardia, Inc. (BCDA)

Role
President and CEO, Director
Signature
/s/ David McClung, by power of attorney
Stock symbol
BCDA
Transactions as of
Aug 17, 2023
Transactions value $
$3,484
Form type
4/A - Amendment
Date filed
8/18/2023, 01:30 PM
Date Of Original Report
Aug 17, 2023
Previous filing
Aug 18, 2023
Next filing
Feb 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCDA Common Stock Purchase $3.48K +4K +0.9% $0.87 447K Aug 17, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades ranging from $0.858 to $0.880 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.